Singular Health Group (SHG) Fair Value & Analysis
Healthcare · AU · Market cap A$68.0M
Fair value as of: Jun 26, 2026
From 1 valuation models · updated 3 days ago
Fair value updated Jun 26, 2026 — revised from A$0.1900 to A$0.0400 (−78.9%) since Jun 24, 2026. Share price −25.0% over the past month.
Price vs Fair Value (12 months)
12‑month range A$0.1701 – A$0.3889 · fair‑value band A$0.0300 – A$0.0500 · the A$0.1750 price screens above the A$0.0400 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Singular Health Group (SHG) currently trades at A$0.1750, while our model-based Fair Value estimate is A$0.0400 — implying the stock looks roughly 77.1% overvalued today. We read business quality at 92/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Trailing-twelve-month revenue stands at A$962K. It earns a return on equity of -90.1%. The balance sheet holds a net cash position of A$13.7M. Fundamentals as of Jun 26, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
Singular Health Group Ltd, a medical technology company, engages in the development and provision of 3DiCom software medical technology in Australia. The company offers volumetric rendering platform which converts 2D medical images into interactive 3D volumetric models for use in visualization, understanding, diagnosis, and treatment planning. It also provides medical file transfer protocol for file transfers, image sharing, and collaboration; and AI in the Cloud for use in medical imaging by integrating AI models, diagnoses, deeper insights, and informed decision-making. Singular Health Group Ltd was incorporated in 2020 and is based in Leederville, Australia.
Revenue & earnings trend
FY2020 – FY2024 · reported fiscal years
Singular Health Group reported revenue of A$558K in FY2024 versus A$194K in FY2020, a compound +30.3%/yr. Reported net income was −A$6.4M in FY2024.
Open the full interactive analysis →
Similar stocks
6 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veeva Systems Inc VEEV | $153.16 | $183.66 | +20% |
| Pro Medicus Limited PME | A$165.64 | A$28.02 | -83% |
| BrightSpring Health Services, Inc BTSG | $60.59 | $23.87 | -61% |
| Tempus AI, Inc TEM | $48.61 | $12.67 | -74% |
| HealthEquity, Inc HQY | $84.61 | $79.57 | -6% |
| M3, Inc MTHRY | $5.03 | $7.44 | +48% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Singular Health Group (SHG) undervalued?
What is the fair value of SHG?
What is the quality score of SHG?
What is the revenue of Singular Health Group (SHG)?
What is the net profit margin of SHG?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.